SR One’s Brian Gallagher Jumps to Abingworth for Partner Post

Xconomy Boston — 

Brian Gallagher is joining London-based Abingworth as a partner based in the life sciences investment firm’s Boston office. Gallagher comes to Abingworth from SR One, the venture capital arm of GlaxoSmithKline (NYSE: GSK), where was a partner. Before SR One, Gallagher was senior director of corporate development at Sirtris Pharmaceuticals, which was acquired by GSK in 2008.